Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Bayer's Former Head of Discovery Lands New CSO Gig at Shire

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

There are some changes taking place in the C-suites at Shire. Source: BioSpace

Continue ReadingBayer's Former Head of Discovery Lands New CSO Gig at Shire

Why This Bay Area Heart Software Biotech Could Become Silicon Valley’s Newest Unicorn

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans. Source: BioSpace

Continue ReadingWhy This Bay Area Heart Software Biotech Could Become Silicon Valley’s Newest Unicorn

Foundation Medicine Wins Approval From the FDA and Medicare for First-of-Its-Kind Cancer Test

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

Foundation Medicine's sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday. Source: BioSpace

Continue ReadingFoundation Medicine Wins Approval From the FDA and Medicare for First-of-Its-Kind Cancer Test

Why This 6-Employee Biotech's Stock Jumped 2,000% in Just Three Days

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA. Source: BioSpace

Continue ReadingWhy This 6-Employee Biotech's Stock Jumped 2,000% in Just Three Days

Higher Death Rate Forces Bayer to Stop Xofigo/Zytiga Combo Late-Stage Study Early

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths. Source: BioSpace

Continue ReadingHigher Death Rate Forces Bayer to Stop Xofigo/Zytiga Combo Late-Stage Study Early

3 Biotechs to Load Up on This Holiday Season

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

These great biotech stocks to buy for the holidays come in all sizes -- small-cap, mid-cap, and large-cap. Source: BioSpace

Continue Reading3 Biotechs to Load Up on This Holiday Season

Amazon in Exploratory Talks With Mylan, Novartis About Pharma Entry

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

Speculation has increased that Amazon might enter the pharmacy market after it conducted high-level talks with generic drug companies Mylan and Sandoz, a division of Novartis. Source: BioSpace

Continue ReadingAmazon in Exploratory Talks With Mylan, Novartis About Pharma Entry

Active Biotech's Laquinimod Fails to Meet Primary Endpoint in Phase II Trial

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

The primary endpoint of brain atrophy as defined by PBVC from baseline to week 48, was not met after daily oral doses with 0.6 mg laquinimod. Source: BioSpace

Continue ReadingActive Biotech's Laquinimod Fails to Meet Primary Endpoint in Phase II Trial

Texas Compounder Warned for Sterility Practices, Other GMP Violations

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:Drug Industry Daily

The FDA issued a warning letter to a Texas drug compounding facility after it failed to resolve problems identified during an inspection, including serious deficiencies in sterile drug processing. Source:…

Continue ReadingTexas Compounder Warned for Sterility Practices, Other GMP Violations

Dr. Reddy’s Hit With Class-Action Suit Claiming False Statements

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:Drug Industry Daily

Dr. Reddy’s Laboratories said it will contest a class-action lawsuit by investors who claim the company made false or misleading statements about its quality system. Source: Drug Industry Daily

Continue ReadingDr. Reddy’s Hit With Class-Action Suit Claiming False Statements
  • Go to the previous page
  • 1
  • …
  • 241
  • 242
  • 243
  • 244
  • 245
  • 246
  • 247
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.